Skip to content
Clinical Trials – home
Centre Hospitalier Universitaire De Poitiers
Sponsor

Centre Hospitalier Universitaire De Poitiers

France 2 Rue De La Miletrie, 86000 Poitiers, France

About the sponsor

Clinical research activity is centred on multiple myeloma, lymphoma, and chronic myeloid leukaemia, with attention to treatment response, disease control, and treatment discontinuation in haematological malignancies.

  • Multiple myeloma
  • Lymphoma
  • Chronic myeloid leukaemia
  • Relapsed or refractory disease

Research also includes older and transplant-ineligible patient populations, reflecting interest in haematologic oncology across different clinical settings.

About Specializations

Centre Hospitalier Universitaire De Poitiers runs clinical trials in conditions such as Plasma cell myeloma, Bronchopulmonary aspergillosis, Breast cancer female, Immunisation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Study Comparing Itraconazole and Nebulised Amphotericin B with Itraconazole Alone for Patients with Chronic Pulmonary Aspergillosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Itraconazole
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Breast cancer female

Not yet recruiting

Study of abemaciclib and its connection to severe diarrhea in patients with hormone receptor-positive breast cancer at high risk of return

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Immunisation

Not yet recruiting

Study on the Effectiveness of Pneumococcal Vaccines PCV13 and PPV23 in Adults with Acute Leukemia or Lymphoma Undergoing Chemotherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pneumococcal polysaccharide serotype 1
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Plasma cell myeloma

Not recruiting

Study on Isatuximab, Pomalidomide, Dexamethasone, and Carfilzomib for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Study on Cefoxitin and Sodium Chloride for Preventing Infections After Colorectal Surgery

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cefoxitin Sodium
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Study on Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: Comparing Dasatinib, Imatinib, Nilotinib, and Bosutinib Strategies

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Plasma cell myeloma

Not recruiting

Study of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Plasma cell myeloma

Not recruiting

Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.